Advancing detection and response capacities for emerging and re-emerging pathogens in Africa
|
|
0
|
234
|
January 8, 2023
|
Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study
|
|
0
|
296
|
December 17, 2022
|
Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis
|
|
0
|
351
|
December 14, 2022
|
Global Health Delivery Intensive 2023
|
|
0
|
439
|
December 4, 2022
|
Antimicrobial Resistance Is Growing because of COVID
|
|
0
|
413
|
November 25, 2022
|
Special issue of Lab Culture: Expanding the diagnostic toolkit for tracking Mycobacterium tuberculosis
|
|
0
|
388
|
November 23, 2022
|
TAG Launches 2022 TB Diagnostics Pipeline Report
|
|
0
|
479
|
November 11, 2022
|
The COugh Diagnostic Algorithm for Tuberculosis (CODA TB) DREAM Challenge
|
|
0
|
1221
|
October 27, 2022
|
1st Australasian Conference on Point of Care Testing for Infectious Diseases (POC 2023)
|
|
0
|
385
|
October 26, 2022
|
Tb diagnostics webinar: where do we go from here?
|
|
0
|
416
|
October 5, 2022
|
Rational design of an essential diagnostics network to support Universal Health Coverage: a modeling analysis
|
|
0
|
385
|
October 5, 2022
|
More at-home tests are heading your way
|
|
0
|
430
|
September 30, 2022
|
Diagnostic Network Optimisation Sub-community of Practice (DNO Sub-CoP)
|
|
0
|
261
|
September 29, 2022
|
Deep Learning Detection of Active Pulmonary Tuberculosis at Chest Radiography Matched the Clinical Performance of Radiologists
|
|
0
|
393
|
September 10, 2022
|
Ten Principles for Access to Multi-disease Molecular Diagnostics: A Global Call to Action
|
|
0
|
486
|
August 23, 2022
|
The Statistics of Counting Coughs: Easy as 1, 2, 3?
|
|
0
|
473
|
August 17, 2022
|
Strengthening resistance testing for tuberculosis in India
|
|
0
|
478
|
August 10, 2022
|
OptiDX — Optimizing Diagnostic Networks
|
|
0
|
625
|
August 7, 2022
|
Innovation in diagnostics: addressing gaps in low- and middle-income countries
|
|
0
|
537
|
August 6, 2022
|
Opportunity for Evaluation of Diagnostic Products (Global Fund and Unitaid)
|
|
0
|
525
|
July 18, 2022
|
PLOS Global Public Health special call for papers on global health diagnostics
|
|
0
|
548
|
July 10, 2022
|
Making cough count in tuberculosis care
|
|
0
|
507
|
July 8, 2022
|
The essential role of diagnostics in global health & development
|
|
0
|
601
|
June 4, 2022
|
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
|
|
0
|
480
|
May 20, 2022
|
Diagnostic Accuracy of Point-of-Care HCV Viral Load Assays for HCV Diagnosis: A Systematic Review and Meta-Analysis
|
|
0
|
466
|
May 19, 2022
|
TB laboratory manuals issued to support the implementation of WHO-recommended diagnostics
|
|
0
|
523
|
May 13, 2022
|
Most common reasons for primary care visits in low- and middle-income countries: A systematic review
|
|
0
|
512
|
May 2, 2022
|
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views
|
|
0
|
479
|
April 27, 2022
|
Fleming Fund Phase I report now available
|
|
0
|
522
|
April 27, 2022
|
Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing
|
|
0
|
443
|
April 20, 2022
|